Pluri Inc. Increase (Decrease) in Other Operating Assets
Pluri Inc. (PLUR) reported Increase (Decrease) in Other Operating Assets of -$303.00 thousand for the 12-month period ending 2021-06-30, per its 10-K filed 2021-09-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2021-09-13
- Pluri Inc. increase (decrease) in other operating assets for the quarter ending 2021-06-30 was -$184.00K.
- Pluri Inc. increase (decrease) in other operating assets for the quarter ending 2021-03-31 was -$298.00K.
- Pluri Inc. increase (decrease) in other operating assets for the quarter ending 2020-12-31 was $444.00K, a 88.14% increase year-over-year.
- Pluri Inc. increase (decrease) in other operating assets for the quarter ending 2020-09-30 was -$265.00K, a 154.87% decline year-over-year.
- Pluri Inc. increase (decrease) in other operating assets for fiscal 2021 was -$303.00K, a 302.00% decline from fiscal 2020.
- Pluri Inc. increase (decrease) in other operating assets for fiscal 2020 was $150.00K, a 62.22% decline from fiscal 2019.
- Pluri Inc. increase (decrease) in other operating assets for fiscal 2019 was $397.00K, a 572.88% increase from fiscal 2018.
- Pluri Inc. increase (decrease) in other operating assets for fiscal 2018 was $59.00K, a 91.93% decline from fiscal 2017.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 9 month as first filed | Increase (Decrease) in Other Operating Assets 12 month | Increase (Decrease) in Other Operating Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2021-06-30 | -$184.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-13 | -$482.00K derived: sum of 2 quarters · filed 2021-09-13 | -$38.00K derived: sum of 3 quarters · filed 2021-09-13 | -$303.00K 10-K · filed 2021-09-13 | ||
| 2021-03-31 | -$298.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-06 | $146.00K derived: sum of 2 quarters · filed 2021-05-06 | -$119.00K 10-Q · filed 2021-05-06 | -$448.00K derived: sum of 4 quarters · filed 2021-09-13 | ||
| 2020-12-31 | $444.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-08 | $179.00K 10-Q · filed 2021-02-08 | -$150.00K derived: sum of 3 quarters · filed 2021-09-13 | -$390.00K derived: sum of 4 quarters · filed 2021-09-13 | ||
| 2020-09-30 | -$265.00K 10-Q · filed 2020-11-05 | -$594.00K derived: sum of 2 quarters · filed 2021-09-13 | -$834.00K derived: sum of 3 quarters · filed 2021-09-13 | -$598.00K derived: sum of 4 quarters · filed 2021-09-13 | ||
| 2020-06-30 | -$329.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-13 | -$569.00K derived: sum of 2 quarters · filed 2021-09-13 | -$333.00K derived: sum of 3 quarters · filed 2021-09-13 | $150.00K 10-K · filed 2021-09-13 | $187.00K 10-K · filed 2020-09-10 | |
| 2020-03-31 | -$240.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-06 | -$4.00K derived: sum of 2 quarters · filed 2021-05-06 | $479.00K 10-Q · filed 2021-05-06 | -$479.00K 10-Q · filed 2020-05-11 | $1.15M derived: sum of 4 quarters · filed 2021-05-06 | |
| 2019-12-31 | $236.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-08 | $719.00K 10-Q · filed 2021-02-08 | $1.39M derived: sum of 3 quarters · filed 2021-02-08 | -$129.00K derived: sum of 4 quarters · filed 2021-02-08 | ||
| 2019-09-30 | $483.00K 10-Q · filed 2020-11-05 | $1.15M derived: sum of 2 quarters · filed 2020-11-05 | -$365.00K derived: sum of 3 quarters · filed 2020-11-05 | $354.00K derived: sum of 4 quarters · filed 2020-11-05 | ||
| 2019-06-30 | $667.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-10 | -$848.00K derived: sum of 2 quarters · filed 2020-09-10 | -$129.00K derived: sum of 3 quarters · filed 2020-09-10 | $397.00K 10-K · filed 2020-09-10 | ||
| 2019-03-31 | -$1.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | -$796.00K derived: sum of 2 quarters · filed 2020-05-11 | -$270.00K 10-Q · filed 2020-05-11 | $270.00K 10-Q · filed 2019-05-06 | $70.00K derived: sum of 4 quarters · filed 2020-09-10 | |
| 2018-12-31 | $719.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06 | $1.25M 10-Q · filed 2020-02-06 | $1.58M derived: sum of 3 quarters · filed 2020-09-10 | $1.58M derived: sum of 4 quarters · filed 2020-09-10 | ||
| 2018-09-30 | $526.00K 10-Q · filed 2019-11-07 | $866.00K derived: sum of 2 quarters · filed 2020-09-10 | $857.00K derived: sum of 3 quarters · filed 2020-09-10 | $415.00K derived: sum of 4 quarters · filed 2020-09-10 | ||
| 2018-06-30 | $340.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-10 | $331.00K derived: sum of 2 quarters · filed 2020-09-10 | -$111.00K derived: sum of 3 quarters · filed 2020-09-10 | $59.00K 10-K · filed 2020-09-10 | ||
| 2018-03-31 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-06 | -$451.00K derived: sum of 2 quarters · filed 2019-05-06 | -$281.00K 10-Q · filed 2019-05-06 | -$153.00K derived: sum of 4 quarters · filed 2019-09-12 | ||
| 2017-12-31 | -$442.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-06 | -$272.00K 10-Q · filed 2019-02-06 | -$144.00K derived: sum of 3 quarters · filed 2019-09-12 | $354.00K derived: sum of 4 quarters · filed 2019-09-12 | ||
| 2017-09-30 | $170.00K 10-Q · filed 2018-11-07 | $298.00K derived: sum of 2 quarters · filed 2019-09-12 | $796.00K derived: sum of 3 quarters · filed 2019-09-12 | $969.00K derived: sum of 4 quarters · filed 2019-09-12 | ||
| 2017-06-30 | $128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-12 | $626.00K derived: sum of 2 quarters · filed 2019-09-12 | $799.00K derived: sum of 3 quarters · filed 2019-09-12 | $731.00K 10-K · filed 2019-09-12 | ||
| 2017-03-31 | $498.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | $671.00K derived: sum of 2 quarters · filed 2018-05-09 | $603.00K 10-Q · filed 2018-05-09 | $246.00K derived: sum of 4 quarters · filed 2018-09-12 | ||
| 2016-12-31 | $173.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-06 | $105.00K 10-Q · filed 2018-02-06 | -$252.00K derived: sum of 3 quarters · filed 2018-09-12 | -$258.00K derived: sum of 4 quarters · filed 2018-09-12 | ||
| 2016-09-30 | -$68.00K 10-Q · filed 2017-11-07 | -$425.00K derived: sum of 2 quarters · filed 2018-09-12 | -$431.00K derived: sum of 3 quarters · filed 2018-09-12 | -$600.00K derived: sum of 4 quarters · filed 2018-09-12 | ||
| 2016-06-30 | -$357.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-12 | -$363.00K derived: sum of 2 quarters · filed 2018-09-12 | -$532.00K derived: sum of 3 quarters · filed 2018-09-12 | -$1.40M 10-K · filed 2018-09-12 | ||
| 2016-03-31 | -$6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-08 | -$175.00K derived: sum of 2 quarters · filed 2017-05-08 | -$1.04M 10-Q · filed 2017-05-08 | |||
| 2015-12-31 | -$169.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-08 | -$1.03M 10-Q · filed 2017-02-08 | ||||
| 2015-09-30 | -$863.00K 10-Q · filed 2016-11-07 | |||||
| 2015-06-30 | $1.13M 10-K · filed 2017-09-07 | |||||
| 2014-06-30 | $251.00K 10-K · filed 2016-09-07 | |||||
| 2013-06-30 | $470.00K 10-K · filed 2015-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |